Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing
Source abstract
Abstract
Skin protects the body from exogenous substances and functions as a barrier to fluid loss and trauma. The skin comprises of epidermal, dermal and hypodermal layers, which mainly contain keratinocytes, fibroblasts and adipocytes, respectively, typically embedded on extracellular matrix made up of glycosaminoglycans and fibrous proteins. When the integrity of skin is compromised due to injury as in burns the coverage of skin has to be restored to facilitate repair and regeneration. Skin substitutes are preferred for wound coverage when the loss of skin is extensive especially in the case of second or third degree burns. Different kinds of skin substitutes with different features are commercially available; they can be classified into acellular skin substitutes, those with cultured epidermal cells and no dermal components, those with only dermal components, and tissue engineered substitutes that contain both epidermal and dermal components. Typically, adult wounds heal by fibrosis. Most organs are affected by fibrosis, with chronic fibrotic diseases estimated to be a leading cause of morbidity and mortality. In the skin, fibroproliferative disorders such as hypertrophic scars and keloid formation cause cosmetic and functional problems. Dermal fibroblasts are understood to be heterogeneous; this may have implications on post-burn wound healing since studies have shown that superficial and deep dermal fibroblasts are anti-fibrotic and pro-fibrotic, respectively. Selective use of superficial dermal fibroblasts rather than the conventional heterogeneous dermal fibroblasts may prove beneficial for post-burn wound healing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Dermatologic Treatments and Research · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Wound Healing Research Group, Division of Plastic and Reconstructive Surgery, University of Alberta, 2D3.81 WMSHC, 8440-112 Street, Edmonton, AB T6G 2B7, Canada
Critical Care Medicine, University of Alberta, 2D3.81 WMSHC, 8440-112 Street, Edmonton, AB T6G 2B7, Canada
References (66)
Show source-provided references
1. Tissue engineering of replacement skin: The crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration10.1098/rsif.2006.0179 ↗
2. Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions10.1111/j.1524-475X.2008.00369.x ↗
3. The extracellular matrix as a scaffold for tissue reconstruction10.1016/S1084952102000940 ↗
4. Basement membranes: structure, assembly and role in tumour angiogenesis10.1038/nrc1094 ↗
5. The extracellular matrix in epithelial biology: Shared molecules and common themes in distant phyla10.1006/dbio.1996.0317 ↗
6. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it10.1002/dvdy.20345 ↗
7. Laminin functions in tissue morphogenesis10.1146/annurev.cellbio.20.010403.094555 ↗
8. Biochemical characteristics of cardiac collagen and its role in ventricular remodelling following infarction
9. Regulation and regulatory activities of transforming growth factor beta10.1615/CritRevEukaryotGeneExpr.v9.i1.30 ↗
10. Laminins of the dermoepidermal junction10.1016/S0945-053X(98)00004-3 ↗
11. Supramolecular assembly of basement membranes10.1002/bies.950180208 ↗
12. There is temporal and spatial expression of alpha1 (IV), alpha2 (IV), alpha5 (IV), alpha6 (IV) collagen chains and beta1 integrins during the development of the basal lamina in an “in vitro” skin model10.1111/1523-1747.ep12336696 ↗
13. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture10.1006/excr.1997.3910 ↗
14. Basement membrane proteoglycans are of epithelial origin in rodent skin10.1111/1523-1747.ep12343940 ↗
15. Fibroblast heterogeneity: More than skin deep10.1242/jcs.01005 ↗
16. National Burn Repository 2013. Available online: http://www.ameriburn.org.
17. A guide to biological skin substitutes10.1054/bjps.2002.3800 ↗
18. Artificial skin, split-thickness autograft and cultured autologous keratinocytes combined to treat a severe burn injury of 93% of TBSA10.1016/S0305-4179(00)00045-0 ↗
19. Prevention and treatment of postburn scars and contracture10.1007/BF02067119 ↗
20. Allogenic skin in the treatment of burns10.1016/j.clindermatol.2004.07.019 ↗
21. Artificial skin10.1146/annurev.med.51.1.231 ↗
22. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes10.1016/S0002-9610(02)00813-9 ↗
23. Engineered skin substitutes: practices and potentials10.1016/j.clindermatol.2004.07.023 ↗
24. Progress and opportunities for tissue-engineered skin10.1038/nature05664 ↗
25. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment10.1097/00004630-200301000-00009 ↗
26. Acellular allodermis in burns surgery: 1-year results of a pilot trial10.1097/00004630-199811000-00012 ↗
27. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model10.1097/01.SAP.0000044252.76804.6B ↗
28. Safety and efficacy of TransCyte for the treatment of partial-thickness burns10.1097/00004630-199907000-00002 ↗
29. Bilayered bioengineered skin substitute (Apligraf): A review of its use in the treatment of venous leg ulcers and diabetic foot ulcers10.2165/00063030-200216060-00005 ↗
30. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds10.1001/archderm.136.10.1225 ↗
31. Apligraf in the treatment of severe mitten deformity associated with recessive dystrophic epidermolysis bullosa10.1097/01.PRS.0000070730.95956.01 ↗
32. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients10.1016/S0305-4179(03)00164-5 ↗
33. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting10.1073/pnas.76.11.5665 ↗
34. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: A five year single-center experience with 30 patients10.1016/S0305-4179(99)00143-6 ↗
35. Cultured epithelial autograft: five years of clinical experience with twenty-eight patients10.1097/00005373-199508000-00020 ↗
36. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial10.1097/SLA.0b013e318210f3bd ↗
37. Clinical and cost efficacy of advanced wound care matrices for venous ulcers
38. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes10.1097/00005373-199305000-00008 ↗
39. Wound repair and regeneration10.1038/nature07039 ↗
40. Cellular and molecular mechanisms of fibrosis10.1002/path.2277 ↗
41. Quality of life of patients with keloid and hypertrophic scarring10.1007/s00403-006-0651-7 ↗
42. Hold, G.L., Untiveros, P., Saunders, K.A., and El-Omar, E.M. (2009). Role of host genetics in fibrosis. Fibrogenesis Tissue Repair, 2.10.1186/1755-1536-2-6 ↗
43. Tissue engineering10.1126/science.8493529 ↗
44. Bridging the gap10.1038/433019a ↗
45. The effect of gelatin-chondroitin sulfate-hyaluronic acid skin substitute on wound healing in SCID mice10.1016/j.biomaterials.2006.07.024 ↗
46. Skin substitutes from cultured cells and collagen-GAG polymers10.1007/BF02518886 ↗
47. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns10.1097/00000658-199512000-00008 ↗
48. Case studies: Treatment of chronic wounds with cultured skin substitutes
49. The 1999 clinical research award. Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for the closure of excised full-thickness burns10.1097/00004630-199920060-00006 ↗
50. Autologous cultured skin substitutes conserve donor autograft in elective treatment of congenital giant melanocytic nevus10.1097/01.PRS.0000138250.41268.41 ↗
51. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns10.1097/00000658-200202000-00016 ↗
52. Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice10.1096/fj.01-0868com ↗
53. Development of a reconstructed human skin model for angiogenesis10.1046/j.1524-475X.2003.11407.x ↗
54. Regulation of pigmentation in cultured skin substitutes by cytometric sorting of melanocytes and keratinocytes10.1111/1523-1747.ep12335766 ↗
55. An in vivo mouse model of human skin substitute containing spontaneously sorted melanocytes demonstrates physiological changes after UVB irradiation10.1111/j.0022-202X.2005.23832.x ↗
56. Organogenesis from dissociated cells: generation of mature cycling hair follicles from skin-derived cells10.1111/j.0022-202X.2005.23716.x ↗
57. “Trooping the color”: Restoring the original donor skin color by addition of melanocytes to bioengineered skin analogs10.1007/s00383-012-3217-0 ↗
58. Marino, D., Luginbühl, J., Scola, S., Meuli, M., and Reichmann, E. (2014). Bioengineering dermo-epidermal skin grafts with blood and lymphatic capillaries. Sci. Transl. Med., 6.10.1126/scitranslmed.3006894 ↗
59. Deep dermal fibroblasts contribute to hypertrophic scarring10.1038/labinvest.2008.101 ↗
60. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: Potential therapeutic targets for hypertrophic scar10.1016/j.biomaterials.2011.06.070 ↗
61. Assessment of burn depth and burn wound healing potential10.1016/j.burns.2008.01.009 ↗
62. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury10.1016/j.burns.2006.02.007 ↗
63. Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue engineered skin: Implications for treatment of skin basement membrane disorders
64. Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes
65. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring10.1097/BCR.0b013e3182335980 ↗
66. Rinkevich, Y., Walmsley, G.G., Hu, M.S., Maan, Z.N., Newman, A.M., Drukker, M., Januszyk, M., Krampitz, G.W., Gurtner, G.C., and Lorenz, H.P. (2015). Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science, 348.10.1126/science.aaa2151 ↗